We are Bio-organic/ Medicinal chemistry group interested in the "Design, Synthesis and Evaluation of Biological Active Molecules”.

Our focus is on synthesizing novel heterocyclic molecules as new therapeutic approaches for cancer and infectious diseases. We plan to develop new compounds that can induce cell differentiation and could act as potential anti-cancer agents. Molecular modeling studies and bioassays will be used to design and characterize the most potent inhibitors.